Veteran journalist, investor, and Second Opinion Media founder Chrissy Farr talks with the CEOs and founders who've been in the trenches long enough to know that healthcare doesn't move at startup speed. These aren't the entrepreneurs chasing quick exits—they're the "lifers" who understand that building in healthcare requires endless pivots, regulatory navigation, and decade-long timelines.
No hype, just honest conversations about what it really takes.
Each episode explores healthcare innovation, startup strategy, medical technology and AI, health system transformation, and investment insights from operators who've navigated regulatory challenges, clinical trials, reimbursement complexities, and the unique dynamics of the healthcare industry.
All content for Lifers with Christina Farr is the property of Christina Farr and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Veteran journalist, investor, and Second Opinion Media founder Chrissy Farr talks with the CEOs and founders who've been in the trenches long enough to know that healthcare doesn't move at startup speed. These aren't the entrepreneurs chasing quick exits—they're the "lifers" who understand that building in healthcare requires endless pivots, regulatory navigation, and decade-long timelines.
No hype, just honest conversations about what it really takes.
Each episode explores healthcare innovation, startup strategy, medical technology and AI, health system transformation, and investment insights from operators who've navigated regulatory challenges, clinical trials, reimbursement complexities, and the unique dynamics of the healthcare industry.
The power of patient data & the future of health tech with Microsoft's Peter Lee and Dave deBronkart
Lifers with Christina Farr
1 hour 25 minutes
6 months ago
The power of patient data & the future of health tech with Microsoft's Peter Lee and Dave deBronkart
This week on Second Opinion, we're sharing an episode from Peter Lee's Microsoft Research Podcast with guests Dave deBronkart and Christina Farr. They examine how AI has transformed healthcare since GPT-4's launch two years ago, with Dave and Chrissy sharing insights on patient empowerment through AI tools and the evolving digital health business models in specialized care areas.
This episode was originally published in the Microsoft Research Podcast: https://www.microsoft.com/en-us/research/podcast/the-ai-revolution-in-medicine-revisited-empowering-patients-and-healthcare-consumers-in-the-age-of-generative-ai/?OCID=AIRevolutionPod_SecondOpinion
—📰 Be notified early when Turpentine drops new publication: https://www.turpentine.co/exclusiveaccess —
SPONSOR:🏋🏻♀️Strengthen your cells from the inside-out with Fatty15, a pure C15 supplement proven to boost energy, improve sleep, and support metabolic, heart, and liver health – without the downsides of fish oil. Ready to restore your long-term health? Get 15% off your 90-day subscription Starter Kit at https://fatty15.com/secondopinion using code SECONDOPINION at checkout.
—LINKS:e-Patient Dave: https://www.epatientdave.com/ Patients Use AI: https://patientsuseai.substack.com/ Meet e-Patient Dave (TED Talk): https://www.ted.com/talks/dave_debronkart_meet_e_patient_dave “Let Patients Help”: A Patient Engagement Handbook: https://www.epatientdave.com/let-patients-help/ There's about to be a lot of Al capital incineration: https://secondopinion.media/p/there-s-about-to-be-a-lot-of-ai-capital-incineration A letter to my kids about last week: https://secondopinion.media/p/a-letter-to-my-kids-about-last-week The AI Revolution in Medicine: GPT-4 and Beyond: https://www.microsoft.com/en-us/research/publication/the-ai-revolution-in-medicine-gpt-4-and-beyond/
Christina Farr's Second Opinion Newsletter: https://secondopinion.media/
—FOLLOW:https://www.linkedin.com/in/peterlee4 https://www.linkedin.com/in/epatientdave/ https://www.linkedin.com/in/christinafarr/
—HIGHLIGHTS FROM THE EPISODE:Dave de Bronkart's Segment:• Diagnosed with stage four kidney cancer in 2007 with 24-week survival expectation.• Online patient community proved crucial to his survival.• Community had treatment knowledge not available in medical literature.• Always verified community information with clinicians before acting.• Sees AI as tool for patients to explore health questions without using doctor's time.• Believes AI won't replace doctors but will help patients solve more issues independently.• Advocates for patient access to their complete medical data.
Chrissy Farr's Segment:• AI startups struggle because healthcare systems can't effectively integrate their tools.• Prefers businesses using AI within care delivery over standalone AI tools.• Healthcare tech works best during "high engagement" moments like pregnancy or cancer diagnosis.• Health systems struggle to justify new technology investments.• Women's health is fertile for digital innovation due to multiple engagement points.• Text messaging services offer better experiences than apps.• Many consumers shifting to cash-pay subscription models.• Short employee tenure challenges employer healthcare investments.• Elder care technologies present significant opportunities.• Healthcare change can come from both outside advocates and inside employees.
Lifers with Christina Farr
Veteran journalist, investor, and Second Opinion Media founder Chrissy Farr talks with the CEOs and founders who've been in the trenches long enough to know that healthcare doesn't move at startup speed. These aren't the entrepreneurs chasing quick exits—they're the "lifers" who understand that building in healthcare requires endless pivots, regulatory navigation, and decade-long timelines.
No hype, just honest conversations about what it really takes.
Each episode explores healthcare innovation, startup strategy, medical technology and AI, health system transformation, and investment insights from operators who've navigated regulatory challenges, clinical trials, reimbursement complexities, and the unique dynamics of the healthcare industry.